Most commonly prescribed antibiotics are safe for people with liver disease, but a few carry meaningful risk and should be avoided or used cautiously. The safest broad categories are penicillins (when used alone), cephalosporins, fluoroquinolones, and tetracyclines like doxycycline. The antibiotics most likely to cause liver problems are amoxicillin-clavulanate (Augmentin), sulfonamide combinations like co-trimoxazole (Bactrim), and certain older macrolides.
Why Liver Disease Changes Antibiotic Safety
A healthy liver processes and clears many medications from the body. When your liver is damaged by cirrhosis, hepatitis, fatty liver disease, or other conditions, drugs that rely on liver metabolism can build up to higher levels in your blood. This increases both side effects and the chance of further liver damage. The medical term for medication-related liver damage is drug-induced liver injury, or DILI, and antibiotics are one of the most common causes, accounting for roughly 2 to 14% of all cases in outpatient settings.
Antibiotics that are cleared mainly through the kidneys tend to be safer choices because they largely bypass the liver entirely. Antibiotics that are heavily processed by the liver may need lower doses or less frequent dosing, especially if your liver disease is moderate to severe. The severity of liver disease is typically graded on a scale called the Child-Pugh classification, which ranges from A (mild) to C (severe). Drugs that need no dose change at Child-Pugh A may be contraindicated at Child-Pugh C.
Antibiotics With the Lowest Liver Risk
Penicillins (Without Clavulanate)
Plain amoxicillin has very little liver-toxic potential when given on its own. Liver injury from standard penicillins ranges from just 1 in 2 million to 3 in 100,000 prescriptions, making them among the safest antibiotic classes for the liver. The critical distinction is that amoxicillin combined with clavulanic acid (sold as Augmentin) is a completely different story, covered below.
Cephalosporins
Cephalosporins, including injectable forms used for serious infections, can be safely given to patients with advanced liver disease. According to the National Library of Medicine’s LiverTox database, dose adjustments are mainly needed for kidney problems rather than liver problems. This makes cephalosporins a go-to choice for many infections in people with cirrhosis or other chronic liver conditions.
Fluoroquinolones
Ciprofloxacin, levofloxacin, and moxifloxacin cause liver injury rarely, at an estimated rate of about 1 in 100,000 people exposed. Minor, temporary bumps in liver enzymes show up in 1 to 3% of patients, but clinically significant damage is uncommon. A large Canadian population study found no meaningful increase in hospital admissions for acute liver injury among people prescribed ciprofloxacin. Levofloxacin has fewer than 1 case of liver injury per 5 million prescriptions.
Doxycycline and Tetracyclines
Tetracyclines as a class have extremely low hepatotoxicity rates, roughly 1 case per 18 million daily doses for standard tetracycline. Doxycycline’s rate is even lower. These are reasonable options when the infection being treated responds to this class.
Antibiotics to Use With Caution
Macrolides
Macrolides occupy a gray area. Erythromycin causes a form of liver inflammation called cholestatic hepatitis at a rate of about 3.6 per 100,000 prescriptions, and clarithromycin has a similar rate of around 3.8 per 100,000. These numbers are low in absolute terms, but they’re notably higher than penicillins or fluoroquinolones.
Azithromycin (Z-Pak) is often considered the safest macrolide, yet it’s not without risk. In a large U.S. study tracking 899 cases of drug-induced liver injury, azithromycin actually accounted for more cases (18) than clarithromycin (2) or erythromycin (2), likely reflecting its much wider use. In rare cases, macrolides can cause a pattern of liver-cell damage that leads to acute liver failure. If you have pre-existing liver disease and need a macrolide, your prescriber will likely weigh this risk carefully.
Metronidazole
Metronidazole is heavily processed by the liver. In people with significant liver impairment, the drug clears much more slowly, which can lead to a buildup of the drug and increased side effects, particularly neurological ones. Dose reductions are typically necessary for moderate to severe liver disease.
Antibiotics to Avoid
Amoxicillin-Clavulanate (Augmentin)
This is the single most important antibiotic to flag. The clavulanic acid component makes this combination one of the most common causes of antibiotic-related liver injury in clinical practice. Liver damage occurs in roughly 1 in 2,500 prescriptions, a rate dramatically higher than nearly any other antibiotic. The injury typically follows a cholestatic pattern, meaning bile flow is disrupted rather than liver cells being directly destroyed. Deaths have been documented, particularly in patients who already had cirrhosis or who were exposed to the drug more than once. If you have liver disease and need a penicillin-type antibiotic, plain amoxicillin is far safer.
Co-trimoxazole (Bactrim, Septra)
The sulfonamide component in co-trimoxazole puts it among the most frequently implicated antibiotics in liver injury. Sulfonamides cause liver damage at an estimated rate of 10 per 100,000 prescriptions. For people with compromised liver function, this risk is amplified.
Flucloxacillin
Despite being a penicillin-type drug, flucloxacillin stands apart from the rest of its class. It is one of the top three antibiotics most frequently linked to liver injury in primary care settings and should be used cautiously or avoided in liver disease.
Telithromycin
This macrolide-related antibiotic (a ketolide) carries a hepatotoxicity rate of about 5.5 per 100,000 prescriptions. It has been specifically singled out as overly hepatotoxic compared to other antibiotics used in general practice and has caused cases of severe liver-cell injury leading to liver failure.
Aminoglycosides and Vancomycin
These drugs aren’t directly toxic to the liver, but they pose a different danger for people with liver disease. Both carry a relatively high risk of kidney damage. Since advanced liver disease (especially cirrhosis) already puts your kidneys under stress, the combination of aminoglycosides with intravenous vancomycin is generally considered contraindicated in this population. Kidney failure in someone with cirrhosis can spiral into a much more dangerous situation than it would in someone with a healthy liver.
What Monitoring Looks Like
If you have liver disease and start a new antibiotic, expect your doctor to order blood tests checking your liver enzymes (ALT, AST, alkaline phosphatase), bilirubin, and albumin. Abnormal baseline liver tests, a history of prior drug-induced liver injury, or taking other medications that stress the liver all increase your risk and may prompt more frequent monitoring.
Symptoms to watch for during any antibiotic course include new or worsening nausea, stomach pain, dark urine, pale stools, yellowing of your skin or eyes, unusual fatigue, and loss of appetite. These can signal that the antibiotic is worsening your liver function, and they warrant prompt contact with your prescriber.
Quick Comparison by Liver Risk
- Lowest risk: Plain penicillins, amoxicillin alone, cephalosporins, doxycycline, levofloxacin
- Low to moderate risk: Ciprofloxacin, azithromycin, clarithromycin, erythromycin
- Higher risk (use cautiously or avoid): Amoxicillin-clavulanate, co-trimoxazole, flucloxacillin, telithromycin, metronidazole in high doses
The severity of your liver disease matters enormously. Someone with mild fatty liver faces a very different risk profile than someone with advanced cirrhosis. Your prescriber should factor in both the type of infection you have and how well your liver is currently functioning before choosing an antibiotic.